OncologyPrimary Bone Tumours

Ewing's Sarcoma - Adolescent Femur

Oncology
Intermediate
6 min
High Yield
Ewing sarcomasmall round blue cell tumourt(11;22) translocationCD99neoadjuvant chemotherapyVIDE protocol
6:00
Start the timer to simulate exam conditions

CIM Case: Ewing's Sarcoma - Adolescent Femur

Clinical Scenario

Patient: 14-year-old male Presentation: 6-week history of progressive right thigh pain and swelling, worse at night, associated with low-grade fevers and night sweats Relevant history: Previously fit and active, no prior bone problems, no trauma, no family history of malignancy, 3kg weight loss over 6 weeks, decreased appetite, fatigue Examination findings:

  • Unwell-appearing adolescent, pale
  • Temperature 37.8°C
  • Palpable warm, tender mass over distal right thigh (8cm × 6cm)
  • Firm, fixed to underlying bone
  • Visible distension of superficial veins over mass
  • Range of motion at knee limited by pain
  • No knee effusion
  • Neurovascularly intact distally
  • No palpable lymphadenopathy
  • Chest clear

Investigations Provided

Laboratory Results

TestResultNormal RangeInterpretation
Hb98 g/L130-160 g/L↓ Anaemia
WCC12.5 ×10⁹/L4-11 ×10⁹/L↑ Leucocytosis
Platelets485 ×10⁹/L150-400 ×10⁹/L↑ Reactive thrombocytosis
CRP65 mg/L<5 mg/L↑ Elevated
ESR85 mm/hr<15 mm/hr↑ Markedly elevated
LDH580 U/L120-250 U/L↑ Elevated (prognostic marker)
ALP245 U/L150-420 U/LNormal (bone turnover)
Uric acid0.48 mmol/L0.15-0.45 mmol/L↑ Slightly elevated

Imaging

Image 1: AP and Lateral Radiographs of Right Femur

Radiological features:

  • Large permeative/moth-eaten lesion in femoral diaphysis
  • "Onion skin" periosteal reaction (lamellated)
  • Codman triangle at proximal margin
  • Lytic destruction without matrix mineralisation
  • No sclerotic rim (aggressive lesion)
  • Soft tissue mass extending from bone
  • Lesion extends approximately 12cm in longitudinal axis

Image 2: MRI Right Femur with Contrast

MRI findings:

  • Large intramedullary tumour with extensive marrow replacement
  • Low T1 signal, high T2 signal, heterogeneous enhancement
  • Large extraosseous soft tissue mass (8 × 6 × 10 cm)
  • Tumour extends into adjacent muscle compartments
  • No skip lesions identified on whole bone imaging
  • Neurovascular bundle displaced but not encased
  • No knee joint involvement

Image 3: CT Chest

Findings:

  • Two small pulmonary nodules (4mm and 6mm) in right lower lobe
  • Concerning for pulmonary metastases
  • No mediastinal lymphadenopathy

Questions & Model Answers

Q

What is your differential diagnosis and most likely diagnosis?

Q

Describe the characteristic features of Ewing sarcoma.

Q

What is your staging workup for this patient?

Q

What is the treatment algorithm for Ewing sarcoma?

Q

This patient has pulmonary metastases. How does this affect management?

Q

Compare Ewing sarcoma with osteosarcoma.


Key Teaching Points

Pattern Recognition

This pattern suggests Ewing Sarcoma:

  • Adolescent (10-20 years) with bone pain and systemic symptoms
  • Diaphyseal or metadiaphyseal location
  • Permeative/moth-eaten destruction on X-ray
  • "Onion skin" lamellated periosteal reaction
  • Large soft tissue mass disproportionate to bone lesion
  • Elevated LDH and inflammatory markers

Age-Based Differential for Round Cell Tumours:

AgeMost Likely Round Cell Tumour
0-5 yearsNeuroblastoma metastasis, leukaemia
5-10 yearsEosinophilic granuloma (LCH)
10-25 yearsEwing sarcoma
25-40 yearsLymphoma
>40 yearsMyeloma, metastases

Small Round Blue Cell Tumours (Differential):

  • Ewing sarcoma (CD99+, t(11;22))
  • Lymphoma (CD45+, CD20/CD3+)
  • Neuroblastoma (NSE+, NB84+)
  • Rhabdomyosarcoma (desmin+, myogenin+)
  • Small cell osteosarcoma (SATB2+, osteoid)

Critical Management Points

  1. Don't treat as infection without biopsy - Ewing mimics osteomyelitis
  2. Whole bone MRI - skip lesions change surgical planning
  3. Biopsy tract planning - must be excised with tumour
  4. Neoadjuvant chemotherapy first - don't proceed directly to surgery
  5. MDT essential - sarcoma surgeon, oncologist, radiologist, pathologist
  6. Histological response matters - >90% necrosis = good prognosis

Common Examiner Follow-ups

Q: "What is the difference between 'onion skin' and 'sunburst' periosteal reaction?"

FeatureOnion SkinSunburst
AppearanceConcentric lamellated layersRadiating spicules
MechanismSlow, intermittent periosteal elevationRapid, continuous tumour growth
Classic tumourEwing sarcomaOsteosarcoma
ImplicationModerately aggressiveHighly aggressive

Q: "What is the role of radiotherapy in Ewing sarcoma?"

Radiotherapy indications:

  • Unresectable tumours (pelvis, spine, skull base)
  • Marginal surgical margins
  • Poor histological response to chemotherapy
  • Lung metastases (whole lung irradiation)

Dose: 45-55 Gy for definitive treatment, 40-45 Gy if combined with surgery

Key point: Unlike osteosarcoma, Ewing sarcoma IS radiosensitive. This makes radiotherapy a viable option for local control when surgery would cause unacceptable morbidity.


Q: "What is a skip lesion and why is it important?"

Skip lesion definition: Separate tumour deposit in the same bone, not contiguous with primary lesion.

  • Occurs in 10-15% of Ewing sarcoma
  • Must image ENTIRE bone with MRI
  • Skip lesion = worse prognosis
  • Surgical resection must include skip lesion
  • May require whole bone resection or diaphyseal resection

Missing a skip lesion leads to local recurrence and treatment failure.


Q: "How would you counsel this patient and family about prognosis?"

For metastatic Ewing sarcoma (this patient):

  • Honest discussion about seriousness of diagnosis
  • 5-year survival approximately 20-30% with lung-only metastases
  • Treatment is intensive (12+ months)
  • Significant side effects (nausea, hair loss, infection risk)
  • Fertility preservation discussion before starting chemotherapy
  • Need for long-term surveillance even if cured
  • Involvement of paediatric oncology nurse, psychologist, social worker
  • Family support resources, youth cancer support groups

  • Osteosarcoma
  • Primary Bone Tumours
  • Bone Tumour Staging (Enneking)
  • Endoprosthetic Reconstruction
  • Chemotherapy Protocols in Bone Sarcoma
  • Rotationplasty